ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Task Force: No Routine Mammograms Until 50

November 20, 2009

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

In Brief: Waxman Now Key House Health Figure; Kennedy Subcommittee Beefed Up with Top Democrats

February 9, 1979

NIH Revises K Series Awards; RFP Available; Program Announcement

June 9, 1995

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005